N. Allen

发表

Efficacy of remission-induction regimens for ANCA-associated vasculitis.

P. Merkel, J. Stone, C. Kallenberg, 2013, The New England journal of medicine.

Wegener's granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s.

G. Hoffman, U. Specks, G. Sharp, 2002, The Journal of rheumatology.

Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).

P. Merkel, J. Stone, John C. Davis, 2005, Arthritis and rheumatism.

Fetal renal vein thrombosis, hydrops fetalis, and maternal lupus anticoagulant. A case report

J. Bowie, N. Allen, M. Hage, 1994, Prenatal diagnosis.

Wegener ’ s Granulomatosis : Survey of 701 Patients in North America . Changes in Outcome in the 1990 s

G. Hoffman, U. Specks, G. Sharp, 2004 .

Systemic thrombosis in patients with antiphospholipid antibodies: lesion distribution and imaging findings.

J. Provenzale, T. Ortel, N. Allen, 1998, AJR. American journal of roentgenology.

Treatment of Mycobacterium haemophilum infection with an antibiotic regimen including clarithromycin

N. Sidhu-Malik, T. Darling, H. Kamino, 1994, The British journal of dermatology.

Relapsing polychondritis affecting the lower respiratory tract.

H. McAdams, N. Allen, J. V. Behar, 2002, AJR. American journal of roentgenology.

Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohort.

D. Schroeder, P. Merkel, J. Stone, 2011, Arthritis and rheumatism.

Reply from the Authors

A. Friedman, T. Devlin, R. Tien, 1996, Neurology.

Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.

P. Merkel, J. Stone, John C. Davis, 2006, Arthritis and rheumatism.

Diagnostic and therapeutic approach to the patient with vasculitis.

B. Haynes, N. Allen, A. Fauci, 1986, The Medical clinics of North America.

Thromboembolism—Another Threat to the Polymorbid Patient with Vasculitis?: High Incidence of Venous Thrombotic Events among Patients with Wegener Granulomatosis: The Wegener’s Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann Intern Med 142: 620–626, 2005

P. Merkel, J. Stone, John C. Davis, 2005 .

Rituximab for the Treatment of Relapses in ANCA-associated Vasculitis

P. Merkel, J. Stone, L. Viviano, 2014 .

Rituximab for the Treatment of Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

P. Merkel, J. Stone, L. Viviano, 2014, Arthritis & rheumatology.

Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.

P. Merkel, J. Stone, C. Kallenberg, 2013, Arthritis and rheumatism.

Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.

E. S. St. Clair, D. Howell, E. Clair, 1996, Clinical nephrology.

Long‐Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis

J. Block, P. Merkel, L. Moreland, 2020, Arthritis care & research.

Brief Communication: High Incidence of Venous Thrombotic Events among Patients with Wegener Granulomatosis: The Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study

P. Merkel, J. Stone, John C. Davis, 2005, Annals of Internal Medicine.

Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors.

S. Studenski, J. Rice, D. Caldwell, 1987, Arthritis and rheumatism.

Herpes zoster in immunocompromised patients: incidence, timing, and risk factors.

P. Merkel, J. Stone, John C. Davis, 2005, The American journal of medicine.

Association of methotrexate, rheumatoid arthritis and lymphoma: report of 2 cases and literature review.

S. Kingsmore, J. Rice, D. Caldwell, 1992, The Journal of rheumatology.

Expression of autoantibodies to recombinant (U1) RNP-associated 70K antigen in systemic lupus erythematosus.

D. Pisetsky, J. Rice, E. S. St. Clair, 1990, Clinical immunology and immunopathology.

Patients with antiphospholipid antibodies: CT and MR findings of the brain.

J. Provenzale, D. Barboriak, T. Ortel, 1996, AJR. American journal of roentgenology.

Primary systemic amyloidosis masquerading as giant cell arteritis. Case report and review of the literature.

N. Allen, J. Rao, 1993, Arthritis and rheumatism.

The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis

J. Feussner, M. Weinberger, E. Oddone, 1996 .

Defective release of tissue plasminogen activator in systemic and cutaneous vasculitis.

S. Pizzo, J. Jordan, N. Allen, 1987, The American journal of medicine.

Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's)

S. Chow, P. Merkel, J. Stone, 2011, Arthritis care & research.

Polymyalgia rheumatica and temporal arteritis.

S. Studenski, N. Allen, 1986, The Medical clinics of North America.

Antiphospholipid antibodies: findings at arteriography.

J. Provenzale, D. Barboriak, T. Ortel, 1998, AJNR. American journal of neuroradiology.

RETROPERITONEAL FIBROSIS: A True Connective Tissue Disease

G. Gilkeson, N. Allen, Nancy B. Allen, 1996 .

Neuroradiologic findings in polyarteritis nodosa.

J. Provenzale, N. Allen, 1996, AJNR. American journal of neuroradiology.

Neuro-Behcet's disease

A. Friedman, T. Devlin, R. Tien, 1995, Neurology.

Hyperrenin-hyperaldosterone-dependent malignant hypertension in polyarteritis nodosa.

R. Mannon, N. Allen, M. Thel, 1993, Southern medical journal.

Antiphospholipid antibodies in patients with Wegener's granulomatosis and polyarteritis nodosa.

T. Ortel, N. Allen, K. D. Moore, 1999, Arthritis and rheumatism.

Wegener granulomatosis: CT and MR findings.

J. Provenzale, N. Allen, 1996, AJNR. American journal of neuroradiology.

Cyclosporin A therapy for Wegener's granulomatosis.

J. Rice, D. Caldwell, N. Allen, 1993, Advances in experimental medicine and biology.

Occult fractures of the knee: tomographic evaluation.

J. Rice, D. Caldwell, N. Allen, 1983, Radiology.

Ureaplasma urealyticum septic arthritis in hypogammaglobulinemia.

V. Kraus, J. Baraniuk, N. Allen, 1988, The Journal of rheumatology.

Limitations of the 1990 American College of Rheumatology Classification Criteria in the Diagnosis of Vasculitis

T. Pincus, N. Allen, J. Rao, 1998, Annals of Internal Medicine.

Giant Cell Arteritis and Polymyalgia Rheumatica

J. Farmer, N. Allen, B. Ferguson, 1987, The Annals of otology, rhinology, and laryngology.

Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

P. Merkel, J. Stone, C. Kallenberg, 2010, The New England journal of medicine.

Pyomyositis and polyarticular septic arthritis from Hemophilus influenzae in a nonimmunocompromised adult.

J. Jordan, N. Allen, V. Hsu, 1987, The Journal of rheumatology.

Cooccurrence of collagenous colitis with seronegative spondyloarthropathy: report of a case and literature review.

J. Wilson, M. Gottfried, N. Allen, 1993, The Journal of rheumatology.

Diagnosis and treatment of the systemic and cutaneous necrotizing vasculitis syndromes.

N. Allen, P. Bressler, 1997, The Medical clinics of North America.

Urinary type II collagen neoepitope as an outcome measure for relapsing polychondritis.

V. Kraus, M. Saltarelli, N. Allen, 2003, Arthritis and rheumatism.

Orbital involvement by Wegener's granulomatosis: imaging findings.

M. Castillo, J. Provenzale, S. Mukherji, 1996, AJR. American journal of roentgenology.

A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).

P. Merkel, J. Stone, Y. Min, 2001, Arthritis and rheumatism.

Atlantoaxial subluxation in juvenile ankylosing spondylitis.

N. Allen, G. W. Kernodle, D. Kredich, 1987, Arthritis and rheumatism.

Isolated atlantoaxial subluxation as the presenting manifestation of inflammatory bowel disease.

J. Jordan, N. Allen, L. Obeid, 1986, The American journal of medicine.

Miscellaneous vasculitic syndromes including Behçet's disease and central nervous system vasculitis.

N. Allen, 1993, Current opinion in rheumatology.

Wegener's granulomatosis involving the breast. Report of three cases and review of the literature.

J. Jordan, N. Allen, W. Rowe, 1987, The American journal of medicine.

Multiple unusual manifestations of Wegener's granulomatosis: breast mass, microangiopathic hemolytic anemia, consumptive coagulopathy, and low erythrocyte sedimentation rate.

J. Jordan, N. Allen, M. Manning, 1986, Arthritis and rheumatism.

The Role of Antineutrophil Cytoplasmic Antibody (c-ANCA) Testing in the Diagnosis of Wegener Granulomatosis: A Literature Review and Meta-analysis

Eugene Oddone, J. Feussner, E. Oddone, 1995, Annals of Internal Medicine.

Large vessel vasculitis of the central nervous system in systemic lupus erythematosus: report and review of the literature.

D. Weiner, N. Allen, 1991, The Journal of rheumatology.

Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.

D. Pisetsky, J. Rice, D. Caldwell, 1988, The American journal of medicine.

Extended Follow-up of Treatment with Rituximab Versus Cyclophosphamide for Remission-Induction of ANCA-Associated Vasculitis : Which Subsets Are At Greatest Risk for Flare?

P. Merkel, J. Stone, C. Kallenberg, 2011 .

Brief Communication: High Incidence of Venous Thrombotic Events among Patients with Wegener Granulomatosis: The Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study.

P. Merkel, J. Stone, John C. Davis, 2005, Annals of internal medicine.

A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis

J. Feussner, M. Weinberger, N. Allen, 1995, The Lancet.

The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event.

P. Merkel, J. Stone, J. Loscalzo, 2007, The Journal of rheumatology.

Multiple myeloma-associated amyloidosis and giant cell arteritis.

N. Allen, J. Burchette, T. Stenzel, 1998, Arthritis and rheumatism.

Acute gout presenting in the manubriosternal joint.

N. Allen, G. W. Kernodle, 1986, Arthritis and rheumatism.

Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan's syndrome.

B. Haynes, J. Kisslo, N. Allen, 1990, The American journal of medicine.

Gouty tophus causing tarsal tunnel syndrome.

N. Allen, S. Martínez, R. Hall, 1996, Journal of clinical rheumatology.

Discrimination of antineutrophil antibodies from antinuclear antibodies using immunofluorescence on neutrophils and HL60 cells.

N. Allen, M. Dooley, V. Christenson, 1991, The Journal of rheumatology.

THU0301 Safety following initiation of rituximab in granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA): interim analysis of the rituximab in anca-associated vasculitis registry (RAVER)

D. Wallace, P. Monach, P. Duncombe, 2017 .

Rocky Mountain spotted fever presenting with acute monarticular arthritis.

D. Sexton, N. Allen, J. Sundy, 1996, Arthritis and rheumatism.

Efficacy of remission-induction regimens for ANCA-associated vasculitis.

C. Kallenberg, L. Viviano, B. Fessler, 2013, The New England journal of medicine.